BIOMEDICA, LIEGE, Belgium--(BUSINESS WIRE)--MabCure, N.V. (“MabCure”) a wholly owned subsidiary of MabCure Inc.(OTC BB:MBCI.OB) and LifeTechLimburg are pleased to announce the establishment of MabCure’s global research facilities on the research campus of Hasselt University where it will collaborate with the Biomedical Research Institute (“BIOMED”).
